Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

1.

Use of recombinant activated factor VII in patients with Glanzmann's thrombasthenia: a review of the literature.

Rajpurkar M, Chitlur M, Recht M, Cooper DL.

Haemophilia. 2014 Jul;20(4):464-71. doi: 10.1111/hae.12473.

PMID:
24948404
[PubMed - in process]
2.

Global Emerging HEmophilia Panel (GEHEP): A Multinational Collaboration for Advancing Hemophilia Research and Treatment.

James P, Kasthuri R, Kruse-Jarres R, Soni A, Kulkarni R, Bidlingmaier C, Chitlur M, Fogarty P, Gomez K, Holm PA, Mahlangu J, Mancuso ME, Mingot-Castellano ME, Dolan G.

Transfus Med Hemother. 2013 Oct;40(5):352-5. doi: 10.1159/000354843. Epub 2013 Aug 26. Review.

PMID:
24273489
[PubMed]
Free PMC Article
3.

Recommendations for performing thromboelastography/thromboelastometry in hemophilia: communication from the SSC of the ISTH.

Chitlur M, Rivard GE, Lillicrap D, Mann K, Shima M, Young G; Factor VIII, Factor IX, and Rare Coagulation Disorders Subcommittee of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.

J Thromb Haemost. 2014 Jan;12(1):103-6. doi: 10.1111/jth.12458. No abstract available.

PMID:
24261669
[PubMed - in process]
4.

Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A.

Pandey GS, Yanover C, Miller-Jenkins LM, Garfield S, Cole SA, Curran JE, Moses EK, Rydz N, Simhadri V, Kimchi-Sarfaty C, Lillicrap D, Viel KR, Przytycka TM, Pierce GF, Howard TE, Sauna ZE; PATH (Personalized Alternative Therapies for Hemophilia) Study Investigators.

Nat Med. 2013 Oct;19(10):1318-24. doi: 10.1038/nm.3270. Epub 2013 Sep 15.

PMID:
24037092
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Management of thrombotic complications in acute lymphoblastic leukemia.

Zia AN, Chitlur M.

Indian J Pediatr. 2013 Oct;80(10):853-62. doi: 10.1007/s12098-013-1158-9. Epub 2013 Aug 4. Review.

PMID:
23912824
[PubMed - indexed for MEDLINE]
6.

Therapeutic and prophylactic ethanol lock therapy in patients with bleeding disorders.

Rajpurkar M, McGrath E, Joyce J, Boldt-MacDonald K, Chitlur M, Lusher J.

Haemophilia. 2014 Jan;20(1):52-7. doi: 10.1111/hae.12241. Epub 2013 Aug 1.

PMID:
23906245
[PubMed - indexed for MEDLINE]
7.

Phenotypes of allo- and autoimmune antibody responses to FVIII characterized by surface plasmon resonance.

Lewis KB, Hughes RJ, Epstein MS, Josephson NC, Kempton CL, Kessler CM, Key NS, Howard TE, Kruse-Jarres R, Lusher JM, Walsh CE, Watts RG, Ettinger RA, Pratt KP; PATH (Personalized Alternative Therapies for Haemophilia) Study Investigators.

PLoS One. 2013 May 8;8(5):e61120. doi: 10.1371/journal.pone.0061120. Print 2013.

PMID:
23667433
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates.

Soucie JM, Monahan PE, Kulkarni R, De Staercke C, Recht M, Chitlur MB, Gruppo R, Hooper WC, Kessler C, Manco-Johnson MJ, Powell J, Pyle M, Riske B, Sabio H, Trimble S.

Transfusion. 2013 May;53(5):1143-4. doi: 10.1111/trf.12153. No abstract available.

PMID:
23659532
[PubMed - indexed for MEDLINE]
9.

Myelofibrosis, hepatic extramedullary hematopoiesis and ascites associated with vitamin D deficiency in early infancy.

Henry M, Chitlur M, Rajpurkar M, Mastropietro CW, Poulik J, Ravindranath Y.

J Pediatr Hematol Oncol. 2014 May;36(4):319-21. doi: 10.1097/MPH.0b013e31828e548a.

PMID:
23619118
[PubMed - indexed for MEDLINE]
10.

Hypodysfibrinogenaemia and thrombosis in association with a new fibrinogen γ chain with two mutations (γ114Tyr→His, and γ320Asp deleted).

Brennan SO, Chitlur M.

Thromb Haemost. 2013 Jun;109(6):1180-2. doi: 10.1160/TH13-01-0068. Epub 2013 Mar 7. No abstract available.

PMID:
23467727
[PubMed - indexed for MEDLINE]
11.

Survey of laboratory tests used in the diagnosis and evaluation of haemophilia A.

Gomez K, Chitlur M; GEHEP panel.

Thromb Haemost. 2013 Apr;109(4):738-43. doi: 10.1160/TH12-02-0108. Epub 2013 Jan 31.

PMID:
23364754
[PubMed - indexed for MEDLINE]
12.

The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Astermark J, Donfield SM, Gomperts ED, Schwarz J, Menius ED, Pavlova A, Oldenburg J, Kessing B, DiMichele DM, Shapiro AD, Winkler CA, Berntorp E; Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Blood. 2013 Feb 21;121(8):1446-54. doi: 10.1182/blood-2012-06-434803. Epub 2012 Dec 6.

PMID:
23223434
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Emergency department visits in children with hemophilia.

Özgönenel B, Zia A, Callaghan MU, Chitlur M, Rajpurkar M, Lusher JM.

Pediatr Blood Cancer. 2013 Jul;60(7):1188-91. doi: 10.1002/pbc.24401. Epub 2012 Nov 28.

PMID:
23192828
[PubMed - indexed for MEDLINE]
14.

Comparison of hematologic measurements between local and central laboratories: data from the BABY HUG trial.

Kalpatthi R, Thompson B, Lu M, Wang WC, Patel N, Kutlar A, Howard T, Luchtman-Jones L, Miller ST; BABY HUG Investigators.

Clin Biochem. 2013 Feb;46(3):278-81. doi: 10.1016/j.clinbiochem.2012.10.032. Epub 2012 Oct 31.

PMID:
23123915
[PubMed - indexed for MEDLINE]
15.

Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening.

Soucie JM, De Staercke C, Monahan PE, Recht M, Chitlur MB, Gruppo R, Hooper WC, Kessler C, Kulkarni R, Manco-Johnson MJ, Powell J, Pyle M, Riske B, Sabio H, Trimble S; US Hemophilia Treatment Center Network.

Transfusion. 2013 Jun;53(6):1217-25. doi: 10.1111/j.1537-2995.2012.03907.x. Epub 2012 Sep 24.

PMID:
22998193
[PubMed - indexed for MEDLINE]
16.

F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Schwarz J, Astermark J, Menius ED, Carrington M, Donfield SM, Gomperts ED, Nelson GW, Oldenburg J, Pavlova A, Shapiro AD, Winkler CA, Berntorp E; Hemophilia Inhibitor Genetics Study Combined Cohort.

Haemophilia. 2013 Jan;19(1):113-8. doi: 10.1111/hae.12004. Epub 2012 Sep 7.

PMID:
22958194
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Challenges in the laboratory analyses of bleeding disorders.

Chitlur M.

Thromb Res. 2012 Jul;130(1):1-6. doi: 10.1016/j.thromres.2012.03.011. Epub 2012 Apr 6. Review.

PMID:
22483776
[PubMed - indexed for MEDLINE]
18.

The international factor IX treatment network survey.

Berntorp E, Shapiro AD, Waters J, Astermark J; International Factor IX Treatment Network.

Haemophilia. 2012 May;18(3):e60-2. doi: 10.1111/j.1365-2516.2012.02767.x. Epub 2012 Mar 8. No abstract available.

PMID:
22404549
[PubMed - indexed for MEDLINE]
19.

Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group.

Kühne T, Berchtold W, Michaels LA, Wu R, Donato H, Espina B, Tamary H, Rodeghiero F, Chitlur M, Rischewski J, Imbach P; Intercontinental Cooperative ITP Study Group.

Haematologica. 2011 Dec;96(12):1831-7. doi: 10.3324/haematol.2011.050799. Epub 2011 Aug 31.

PMID:
21880634
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Value assignment of the WHO 6th International Standard for blood coagulation factor VIII and von Willebrand factor in plasma (07/316).

Hubbard AR, Hamill M, Beeharry M, Bevan SA, Heath AB; SSC Sub-Committees on Factor VIII/Factor IX and von Willebrand factor of ISTH.

J Thromb Haemost. 2011 Oct;9(10):2100-2. doi: 10.1111/j.1538-7836.2011.04471.x. No abstract available.

PMID:
21848692
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk